Elmaci, I. Et Al. 2019. From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM. METABOLIC BRAIN DISEASE , vol.34, no.3 , 687-704.

Elmaci, I., ÖZPINAR, A., Ozpinar, A., Perez, J. L., & Altinoz, M. A., (2019). From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM. METABOLIC BRAIN DISEASE , vol.34, no.3, 687-704.

Elmaci, ILHAN Et Al. "From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM," METABOLIC BRAIN DISEASE , vol.34, no.3, 687-704, 2019

Elmaci, ILHAN Et Al. "From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM." METABOLIC BRAIN DISEASE , vol.34, no.3, pp.687-704, 2019

Elmaci, I. Et Al. (2019) . "From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM." METABOLIC BRAIN DISEASE , vol.34, no.3, pp.687-704.

@article{article, author={ILHAN Elmaci Et Al. }, title={From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM}, journal={METABOLIC BRAIN DISEASE}, year=2019, pages={687-704} }